Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-12-012726)

Filing Details

Accession Number:: 0001437749-12-012726
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-12-10 20:01:11
Reporting Period:: 2012-12-06

Filing Date:: 2012-12-10
Accepted Time:: 2012-12-10 20:01:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389545	Novabay Pharmaceuticals Inc.	NBY	Pharmaceutical Preparations (2834)	680454536

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1410081	Ramin Najafi	C/O Novabay Pharmaceuticals, Inc. 5980 Horton Street, Suite 550 Emeryville CA 94608	Chief Executive Officer	Yes	Yes	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-12-06	20,000	$1.24	100,195	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants to Purchase Common Shares	Acquisiton	2012-12-06	15,000	$0.01	15,000	$1.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,000	2012-12-11	2013-12-11	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,117,500	Indirect	By the Najafi Family Trust Dated September 13, 2006

Footnotes

Dr. Najafi purchased 20,000 Common stock with 15,000 warrants to purchase common stock at the Public offering priced on December 6, 2012.